INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience

EuroIntervention 2016;12:760-767. DOI: 10.4244/EIJV12I6A124

Jochen Wöhrle*, MD, FESC; Birgid Gonska, MD; Christoph Rodewald, MD; Julia Seeger, MD; Dominik Scharnbeck, MD; Wolfgang Rottbauer, MD

Department of Internal Medicine II, University of Ulm, Ulm, Germany

Aims: The aim of the study was to evaluate the procedural and 30-day results for the repositionable Lotus valve in patients undergoing transfemoral aortic valve implantation in a single-c

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic regurgitationaortic stenosislotustavivarc-2

Interventions for valvular diseaseTAVITools, devices and techniques

Share on Facebook Share on Twitter Share on Linkedin

Latest news

NEW ISSUE

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

EDITORIAL

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

Trials Book

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Redo-TAVI, Major bleeding in the Amulet Observational Study, OCT findings in ESR...